We are delighted to introduce you to our new RSC Pharmaceutics Editorial Board member, Dr Alexandros Sofias. He is also an Associate Editor and will handle all review submissions to RSC Pharmaceutics.
Dr Alexandros Sofias is the head of the “Immune Cell Targeting and Imaging” laboratory at the Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Hospital, Aachen, Germany. His research focuses on unraveling the intricate in vivo fate of cancer nanomedicine using multimodal and multiscale imaging techniques, and developing nanoimmunotherapeutics for targeting and manipulating the cancer-associated immune system in the tumor microenvironment, circulation, and hematopoietic organs.
His lab is funded by the prestigious JPI Fellowship from the Excellence Initiative of the German Research Foundation (DFG), as well as research grants from the German Cancer Aid (Krebshilfe), the Clinical Research Unit (CRU) program of the German Research Foundation (DFG, CRU 344), the START Program (Faculty of Medicine, RWTH), and the Euro-Bioimaging. He also serves as Conference Chair for the Controlled Release Society (CRS) 2027 Annual Meeting (Toronto, 12-15 July 2027), Elected Member of the European Society for Molecular Imaging (ESMI) Governing Board, and Editorial Board Member for Advanced Drug Delivery Reviews (ADDR) and npj Imaging.
Read some of Dr Alexandros Sofias’s work here:
Neutrophil Hitchhiking Enhances Liposomal Dexamethasone Therapy of Sepsis
Ritvik Mathur, Sara Elsafy, Adrian T Press, Julian Brück, Mathias Hornef, Lukas Martin, Tobias Schürholz, Gernot Marx, Matthias Bartneck, Fabian Kiessling, Josbert Maarten Metselaar, Gert Storm, Twan Lammers, Alexandros Marios Sofias, Patrick Koczera
ACS Nano, 2024, 18, 28866
Intravital microscopy for real-time monitoring of drug delivery and nanobiological processes
Jeffrey Momoh, Dimitrios Kapsokalyvas, Michael Vogt, Sjoerd Hak, Fabian Kiessling, Marc van Zandvoort, Twan Lammers, Alexandros Marios Sofias
Adv. Drug Delivery Rev., 2022, 189, 114528
RSC Pharmaceutics is a new gold open access journal from the Royal Society of Chemistry and publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. This journal is open for submissions.
Check out our author guidelines for information on our article types or find out more about the advantages of publishing in a Royal Society of Chemistry journal.
Keep up to date with our latest news by following us on LinkedIn or BlueSky. You can also keep informed by signing up to our E-Alerts.